eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO
Provided By GlobeNewswire
Last update: Apr 2, 2025
Expanded leadership team as eXoZymes ramps up commercial growth
Damien Perriman brings more than two decades of experience in successfully developing and commercializing novel biotechnologies
Read more at globenewswire.comNASDAQ:EXOZ (4/24/2025, 11:30:56 AM)
12.5
-1.03 (-7.61%)
Find more stocks in the Stock Screener
